Callum Holloway

Verify authorization and documentation before treatment to prevent denials.

Recover the underpayments payers make quietly through systematic variance tracking.

How infusion claims move through Medicare's four-level appeal process before federal court.

Infusion practices need specialized PA workflows, not generalist billing staff scaled up.

Grouping denials by root cause instead of payer language doubles your appeal win rate.

Medicare claws back infusion payments when audits find overpayments, threatening cash flow.

Most infusion appeal letters target the wrong problem and lose.

Specialty infusion billing demands tools built for high-cost drug claims.

End-to-end infusion billing requires tracking drug, authorization, and payer rules together.

Infusion practices need J-code-specific contract language to protect margin.

Knowing which model fits your practice depends on your payer mix and tolerance for inventory risk.